Victoria Vakiener, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 17,988 shares at $21.91 ($394K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
Scheduled sale ($394k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.91 | 8,994 | $197K | 50.0% |
| 2 | $21.91 | 8,994 | $197K | 50.0% |
| Total | $21.91 avg | 17,988 | $394K | 100% |
| Filing → |
| ARWR | SELL | 2024-01-16 | $317K | — | Filing → |
| ARWR | SELL | 2023-10-02 | $41K | — | Filing → |
| EPZM | SELL | 2021-02-05 | $9K | — | Filing → |